Skip to content

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Sustained Attention in Lowlanders

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Global Cognitive Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02738307
Enrollment
18
Registered
2016-04-14
Start date
2016-03-01
Completion date
2017-12-31
Last updated
2018-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of High Altitude

Keywords

High Altitude, Attention, Cognitive Function, Acclimatization, Sleep

Brief summary

Prospective interventional trial in lowlanders evaluating the effect of acute exposure, acclimatization and re-exposure to high altitude on global cognitive function.

Detailed description

Baseline measurements will be performed in Santiago de Chile, 520 m, over the course of 3 days. Participants will then travel by commercial airline (2 h flight) and by bus (2 h ride) to the ALMA base camp located at 2900 m near San Pedro de Atacama, northern Chile. Participants will stay there for the next 7 nights and they will be spend the days (6 total; 6-8 h daily) at the telescope station at 5050 m while undergoing testing as described above at the first and the last day at 5050m. Daily transports from 2900 to 5050 m will be by car (1 h ride, one way). After the first 7 day altitude sojourn participants will return to the Santiago area (520 m) for a 7 day recovery period. A second altitude sojourn with an identical schedule as the one described above and a final low altitude stay of 3 days will follow.

Interventions

Acute high altitude exposure followed by 8 day acclimatization and re-exposure for 8 days after 6 days at low altitude

Sponsors

University of Zurich
CollaboratorOTHER
Marc Poulin
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* born, raised and currently living \<1300m * No overnight stays at altitudes \>1500m 4 weeks before the study

Exclusion criteria

* previous altitude intolerance \<3000m * pregnancy * health impairment, which requires regular treatment

Design outcomes

Primary

MeasureTime frameDescription
Change in global cognitive function assessed by neuropsychological test batteryLow altitude sojourn at 520m (Baseline); first sojourn at 5050m Day 2, 7; second sojourn at 5050m Day 2, 7 (each sojourn cycle = 7 days)Change in global cognition measured across two cycles of altitude exposure, comparing 5050m to 520m

Secondary

MeasureTime frameDescription
Change in cognitive subdomains (visual memory, executive function, working memory and planning, attention, semantic/verbal memory, decision-making and response control) assessed by neuropsychological test batteryLow altitude sojourn at 520m (Baseline); first sojourn at 5050m Day 2, 7; second sojourn at 5050m Day 2, 7 (each sojourn cycle = 7 days)Change in cognitive subdomains (visual memory, executive function, working memory and planning, attention, semantic/verbal memory, decision-making and response control) measured across two cycles of altitude exposure, comparing 5050m to 520m
Change in oxidative stress measured by venous blood samplingLow altitude sojourn at 520m (Baseline); first sojourn at 5050m Day 2, 7; second sojourn at 5050m Day 2, 7 (each sojourn cycle = 7 days)Change in oxidative stress measured before and after high altitude exposure

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026